{"altmetric_id":1223319,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[52296],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"\u2002The KYOTO HEART Study demonstrated that Valsartan Add-on treatment was effective to reduce new-onset diabetes in high-risk hypertensive patients. The purpose of the present study was to examine the effects of Valsartan Add-on treatment on cardiovascular (CV) events in patients with or without diabetes.","abstract_source":"pubmed","altmetric_jid":"4f6fa6113cf058f610006ec8","authors":["Kimura S","Sawada T","Shiraishi J","Yamada H","Matsubara H"],"first_seen_on":"2013-02-06T19:15:39+00:00","issns":[],"issue":"","journal":"Circulation Journal","last_mentioned_on":1360157160,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22987054"],"pmid":"22987054","pubdate":"2012-09-20T00:00:00+00:00","scopus_subjects":["Medicine","Health Sciences"],"subjects":["cardiology"],"title":"Effects of Valsartan on Cardiovascular Morbidity and Mortality in High-Risk Hypertensive Patients With New-Onset Diabetes Mellitus.","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/effects-valsartan-cardiovascular-morbidity-mortality-highrisk-hypertensive-patients-newonset-diabete"},"altmetric_score":{"score":6.336,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6.336},"context_for_score":{"all":{"total_number_of_other_articles":3685758,"mean":4.9523304688866,"rank":490226,"this_scored_higher_than_pct":86,"this_scored_higher_than":3195405,"rank_type":"exact","sample_size":3685758,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":281432,"mean":5.837441276903,"rank":45759,"this_scored_higher_than_pct":83,"this_scored_higher_than":235671,"rank_type":"exact","sample_size":281432,"percentile":83},"this_journal":{"total_number_of_other_articles":476,"mean":1.1372926315789,"rank":11,"this_scored_higher_than_pct":97,"this_scored_higher_than":465,"rank_type":"exact","sample_size":476,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":47,"mean":0.875,"rank":2,"this_scored_higher_than_pct":95,"this_scored_higher_than":45,"rank_type":"exact","sample_size":47,"percentile":95}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":3,"Student  > Master":1,"Other":1},"by_discipline":{"Medicine and Dentistry":5}}},"geo":{"mendeley":{"JP":2}}},"posts":{"blogs":[{"title":"\u30d0\u30eb\u30b5\u30eb\u30bf\u30f3\u306e\u52b9\u679c\u306b\u95a2\u3059\u308b\u8ad6\u6587\uff13\u672c\u304c\u7570\u4f8b\u306e\u64a4\u56de","url":"http:\/\/www.watarase.ne.jp\/aponet\/blog\/130207.html","citation_ids":[724368,1212913,688875,1223319,701938],"posted_on":"2013-02-06T13:26:00+00:00","summary":"\u00a0\u3053\u306e\u5206\u91ce\u306f\u3042\u307e\u308a\u5f97\u610f\u3067\u306f\u306a\u3044\u306e\u3067\u3059\u304c\u3001\u65e5\u520a\u85ac\u696d\u306e\u8a18\u4e8b\u304c\u6c17\u306b\u306a\u308a\u8abf\u3079\u3066\u307f\u307e\u3057\u305f\u3002 \u30ce\u30d0\u30eb\u30c6\u30a3\u30b9\u3000\u3000\u30c7\u30a3\u30aa\u30d0\u30f3\u6709\u529b\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u4f7f\u7528\u4e2d\u6b62 \uff08\u65e5\u520a\u85ac\u696dWEB\u30d5\u30ea\u30fc\u30b5\u30a4\u30c8 2013.02.06\uff09 http:\/\/nk.jiho.j &#8230; Continue reading &#8594;","author":{"name":"\u30a2\u30dd\u30cd\u30c3\u30c8R\u7814\u7a76\u4f1a\u30fb\u6700\u8fd1\u306e\u8a71\u984c","url":"http:\/\/www.watarase.ne.jp\/aponet\/blog","description":"\u73fe\u5834\u306e\u85ac\u5264\u5e2b\u306b\u95a2\u9023\u3059\u308b\u3001\u539a\u52b4\u7701\u60c5\u5831\u30fb\u65b0\u805e\u5831\u9053\u30fbWEB\u60c5\u5831\u30fb\u6d77\u5916\u5831\u9053\u7b49\u3067\u3059"}}]}}